300 related articles for article (PubMed ID: 17096678)
1. Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.
Tornøe CW; Agersø H; Senderovitz T; Nielsen HA; Madsen H; Karlsson MO; Jonsson EN
Br J Clin Pharmacol; 2007 Jun; 63(6):648-64. PubMed ID: 17096678
[TBL] [Abstract][Full Text] [Related]
2. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.
Steinberg M
Clin Ther; 2009; 31 Pt 2():2312-31. PubMed ID: 20110043
[TBL] [Abstract][Full Text] [Related]
3. Semi-mechanistic pharmacodynamic modeling for degarelix, a novel gonadotropin releasing hormone (GnRH) blocker.
Jadhav PR; Agersø H; Tornøe CW; Gobburu JV
J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):609-34. PubMed ID: 16967346
[TBL] [Abstract][Full Text] [Related]
4. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
Erb K; Pechstein B; Schueler A; Engel J; Hermann R
Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
[TBL] [Abstract][Full Text] [Related]
5. A preclinical pharmacokinetic/pharmacodynamic approach to determine a dose of GnRH, for treatment of ovarian follicular cyst in cattle.
Monnoyer S; Guyonnet J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):527-35. PubMed ID: 15601446
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays.
Schneider F; Bellmann A; Becker F; Bambang Poernomo S; Rehfeldt C; Nürnberg G; Kanitz W
Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):235-44. PubMed ID: 12148088
[TBL] [Abstract][Full Text] [Related]
7. Effects of a gonadotropin-releasing hormone agonist implant on reproduction in a male marsupial, Macropus eugenii.
Herbert CA; Trigg TE; Renfree MB; Shaw G; Eckery DC; Cooper DW
Biol Reprod; 2004 Jun; 70(6):1836-42. PubMed ID: 14973259
[TBL] [Abstract][Full Text] [Related]
8. Degarelix: a new approach for the treatment of prostate cancer.
Persson BE; Kold Olesen T; Jensen JK
Neuroendocrinology; 2009; 90(3):235-44. PubMed ID: 19602868
[TBL] [Abstract][Full Text] [Related]
9. Atrazine inhibits pulsatile luteinizing hormone release without altering pituitary sensitivity to a gonadotropin-releasing hormone receptor agonist in female Wistar rats.
Foradori CD; Hinds LR; Hanneman WH; Legare ME; Clay CM; Handa RJ
Biol Reprod; 2009 Jul; 81(1):40-5. PubMed ID: 19299313
[TBL] [Abstract][Full Text] [Related]
10. Comparative response of rams and bulls to long-term treatment with gonadotropin-releasing hormone analogs.
Jiménez-Severiano H; D'Occhio MJ; Lunstra DD; Mussard ML; Davis TL; Enright WJ; Kinder JE
Anim Reprod Sci; 2007 Apr; 98(3-4):204-24. PubMed ID: 16616998
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
Heitman LH; Ijzerman AP
Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
[TBL] [Abstract][Full Text] [Related]
12. Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer.
Van Poppel H; Tombal B; de la Rosette JJ; Persson BE; Jensen JK; Kold Olesen T
Eur Urol; 2008 Oct; 54(4):805-13. PubMed ID: 18538469
[TBL] [Abstract][Full Text] [Related]
13. Female pheromones stimulate release of luteinizing hormone and testosterone without altering GnRH mRNA in adult male Syrian hamsters (Mesocricetus auratus).
Richardson HN; Nelson AL; Ahmed EI; Parfitt DB; Romeo RD; Sisk CL
Gen Comp Endocrinol; 2004 Sep; 138(3):211-7. PubMed ID: 15364203
[TBL] [Abstract][Full Text] [Related]
14. Regulation of thyroid hormones on the production of testosterone in rats.
Chiao YC; Lee HY; Wang SW; Hwang JJ; Chien CH; Huang SW; Lu CC; Chen JJ; Tsai SC; Wang PS
J Cell Biochem; 1999 Jun; 73(4):554-62. PubMed ID: 10733348
[TBL] [Abstract][Full Text] [Related]
15. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats.
Thompson EL; Murphy KG; Patterson M; Bewick GA; Stamp GW; Curtis AE; Cooke JH; Jethwa PH; Todd JF; Ghatei MA; Bloom SR
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1074-82. PubMed ID: 16787965
[TBL] [Abstract][Full Text] [Related]
16. Control of luteinizing hormone and testosterone secretion in a flexibly breeding male passerine, the Rufous-winged Sparrow, Aimophila carpalis.
Deviche P; Small T; Sharp P; Tsutsui K
Gen Comp Endocrinol; 2006 Dec; 149(3):226-35. PubMed ID: 16876798
[TBL] [Abstract][Full Text] [Related]
17. Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep.
Manikkam M; Thompson RC; Herkimer C; Welch KB; Flak J; Karsch FJ; Padmanabhan V
Biol Reprod; 2008 Apr; 78(4):648-60. PubMed ID: 18094361
[TBL] [Abstract][Full Text] [Related]
18. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
[TBL] [Abstract][Full Text] [Related]
19. Lamprey GnRH-III stimulates FSH secretion in barrows.
Kauffold J; Schneider F; Zaremba W; Brüssow KP
Reprod Domest Anim; 2005 Oct; 40(5):475-9. PubMed ID: 16149955
[TBL] [Abstract][Full Text] [Related]
20. Degarelix for prostate cancer.
Doehn C; Sommerauer M; Jocham D
Expert Opin Investig Drugs; 2009 Jun; 18(6):851-60. PubMed ID: 19453267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
